{
    "title": "103_hr5253",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``Medical Malpractice Reform Act of \n1994''.\n\nSEC. 2. CALCULATION AND PAYMENT OF DAMAGES IN MEDICAL MALPRACTICE \n              CLAIMS AND ACTIONS.\n\n    (a) Limitation on Noneconomic Damages.--The total amount of \nnoneconomic damages that may be awarded to a claimant and the members \nof the claimant's family for losses resulting from the injury which is \nthe subject of a medical malpractice liability claim or action may not \nexceed $250,000, regardless of the number of parties against whom the \nclaim or action is brought or the number of actions brought with \nrespect to the injury.\n    (b) Mandatory Offsets for Damages Paid by a Collateral Source.--\n            (1) In general.--With respect to a medical malpractice \n        liability claim or action, the total amount of damages received \n        by an individual under such claim or action shall be reduced, \n        in accordance with paragraph (2), by any other payment that has \n        been, or will be, made to an individual to compensate such \n        individual for the injury that was the subject of such claim or \n        action.\n            (2) Amount of reduction.--The amount by which an award of \n        damages to an individual for an injury shall be reduced under \n        paragraph (1) shall be--\n                    (A) the total amount of any payments (other than \n                such award) that have been made or that will be made to \n                such individual to pay costs of or compensate such \n                individual for the injury that was the subject of the \n                claim or action; minus\n                    (B) the amount paid by such individual (or by the \n                spouse, parent, or legal guardian of such individual) \n                to secure the payments described in subparagraph (A).\n    (c) Periodic Payments for Future Losses.--\n            (1) General rule.--In any medical malpractice liability \n        claim or action in which future economic damages exceed \n        $100,000, a defendant may not be required to pay such damages \n        in a single, lump-sum payment, but shall be permitted to make \n        such payments periodically based on when the damages are found \n        likely to occur, as such payments are determined by the court.\n            (2) Waiver.--A court may waive the application of paragraph \n        (1) with respect to a defendant if the court determines that it \n        is not in the best interests of the plaintiff to receive \n        payments for damages on such a periodic basis.\n\nSEC. 3. LIMITATION ON ATTORNEYS' CONTINGENCY FEES AND OTHER COSTS UNDER \n              MEDICAL MALPRACTICE CLAIMS.\n\n    (a) In General.--An attorney who represents, on a contingency fee \nbasis, a claimant in a medical malpractice liability claim may not \ncharge, demand, receive, or collect for services rendered in connection \nwith such claim in excess of the following amount recovered by judgment \nor settlement under such claim:\n            (1) 25 percent of the first $150,000 (or portion thereof) \n        recovered, plus\n            (2) 10 percent of any amount in excess of $150,000 \n        recovered.\n    (b) Calculation of Periodic Payments.--In the event that a judgment \nor settlement includes periodic or future payments of damages, the \namount recovered for purposes of computing the limitation on the \ncontingency fee under subsection (a) shall be based on the cost of the \nannuity or trust established to make the payments. In any case in which \nan annuity or trust is not established to make such payments, such \namount shall be based on the present value of the payments.\n\nSEC. 4. APPLICABILITY; EFFECT ON STATE LAW.\n\n    (a) Applicability.--This Act shall apply with respect to any \nmedical malpractice liability claim and to any medical malpractice \nliability action brought in any State or Federal court, except that \nthis subtitle shall not apply to a claim or action for damages arising \nfrom a vaccine-related injury or death to the extent that title XXI of \nthe Public Health Service Act applies to the claim or action.\n    (b) Preemption.--The provisions of this Act shall preempt any State \nlaw to the extent such law is inconsistent with such provisions, except \nthat such provisions shall not preempt any State law that places \ngreater limitations on the amount of damages that may be awarded or the \namount of attorneys' fees that may be collected with respect to medical \nmalpractice liability claims.\n    (c) Effect on Sovereign Immunity and Choice of Law or Venue.--\nNothing in subsection (b) shall be construed to--\n            (1) waive or affect any defense of sovereign immunity \n        asserted by any State under any provision of law;\n            (2) waive or affect any defense of sovereign immunity \n        asserted by the United States;\n            (3) affect the applicability of any provision of the \n        Foreign Sovereign Immunities Act of 1976;\n            (4) preempt State choice-of-law rules with respect to \n        claims brought by a foreign nation or a citizen of a foreign \n        nation; or\n            (5) affect the right of any court to transfer venue or to \n        apply the law of a foreign nation or to dismiss a claim of a \n        foreign nation or of a citizen of a foreign nation on the \n        ground of inconvenient forum.\n    (d) Federal Court Jurisdiction Not Established on Federal Question \nGrounds.--Nothing in this Act shall be construed to establish any \njurisdiction in the district courts of the United States over medical \nmalpractice liability actions on the basis of section 1331 or 1337 of \ntitle 28, United States Code.\n\nSEC. 5. DEFINITIONS.\n\n    As used in this Act:\n            (1) Claimant.--The term ``claimant'' means any person who \n        alleges a medical malpractice liability claim, and any person \n        on whose behalf such a claim is alleged, including the decedent \n        in the case of an action brought through or on behalf of an \n        estate.\n            (2) Economic damages.--The term ``economic damages'' means \n        damages paid to compensate an individual for hospital and other \n        medical expenses, lost wages, lost employment, and other \n        pecuniary losses.\n            (3) Health care professional.--The term ``health care \n        professional'' means any individual who provides health care \n        services in a State and who is required by the laws or \n        regulations of the State to be licensed or certified by the \n        State to provide such services in the State.\n            (4) Health care provider.--The term ``health care \n        provider'' means any organization or institution that is \n        engaged in the delivery of health care services in a State and \n        that is required by the laws or regulations of the State to be \n        licensed or certified by the State to engage in the delivery of \n        such services in the State.\n            (5) Injury.--The term ``injury'' means any illness, \n        disease, or other harm that is the subject of a medical \n        malpractice liability action or a medical malpractice liability \n        claim.\n            (6) Medical malpractice liability action.--The term \n        ``medical malpractice liability action'' means a civil action \n        brought in a State or Federal court against a health care \n        provider or health care professional in which the plaintiff \n        alleges a medical malpractice liability claim, but does not \n        include any action in which the plaintiff's sole allegation is \n        an allegation of an intentional tort.\n            (7) Medical malpractice liability claim.--The term \n        ``medical malpractice liability claim'' means a claim in which \n        the claimant alleges that injury was caused by the provision of \n        (or the failure to provide) health care services or the use of \n        a medical product.\n            (8) Medical product.--\n                    (A) In general.--The term ``medical product'' \n                means, with respect to the allegation of a claimant, a \n                drug (as defined in section 201(g)(1) of the Federal \n                Food, Drug, and Cosmetic Act (21 U.S.C. 321(g)(1)) or a \n                medical device (as defined in section 201(h) of the \n                Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321(h)) \n                if--\n                            (i) such drug or device was subject to \n                        premarket approval under section 505, 507, or \n                        515 of the Federal Food, Drug, and Cosmetic Act \n                        (21 U.S.C. 355, 357, or 360e) or section 351 of \n                        the Public Health Service Act (42 U.S.C. 262) \n                        with respect to the safety of the formulation \n                        or performance of the aspect of such drug or \n                        device which is the subject of the claimant's \n                        allegation or the adequacy of the packaging or \n                        labeling of such drug or device, and such drug \n                        or device is approved by the Food and Drug \n                        Administration; or\n                            (ii) the drug or device is generally \n                        recognized as safe and effective under \n                        regulations issued by the Secretary of Health \n                        and Human Services under section 201(p) of the \n                        Federal Food, Drug, and Cosmetic Act (21 U.S.C. \n                        321(p)).\n                    (B) Exception in case of misrepresentation or \n                fraud.--Notwithstanding subparagraph (A), the term \n                ``medical product'' shall not include any product \n                described in such subparagraph if the claimant shows \n                that the product is approved by the Food and Drug \n                Administration for marketing as a result of withheld \n                information, misrepresentation, or an illegal payment \n                by manufacturer of the product.\n            (9) Noneconomic damages.--The term ``noneconomic damages'' \n        means damages paid to compensate an individual for physical and \n        emotional pain, suffering, inconvenience, physical impairment, \n        mental anguish, disfigurement, loss of enjoyment of life, loss \n        of consortium, and other nonpecuniary losses, but does not \n        include punitive damages.\n            (10) Punitive damages.--The term ``punitive damages'' means \n        compensation, in addition to compensation for actual harm \n        suffered, that is awarded for the purpose of punishing a person \n        for conduct deemed to be malicious, wanton, willful, or \n        excessively reckless.\n            (11) State.--The term ``State'' means each of the several \n        States, the District of Columbia, the Commonwealth of Puerto \n        Rico, the Virgin Islands, Guam, and American Samoa.\n\nSEC. 6. EFFECTIVE DATE.\n\n    This Act shall apply with respect to claims accruing or actions \nbrought on or after the date of the enactment of this Act."
}